SGA
GMAB icon

Seaport Global Advisors’s Genmab GMAB Stock Holding History

Seaport Global Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,846
Closed -$1.14M – 110
2021
Q4 		$1.14M Buy
+2,846
New +$119K 1.54% 18

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Seaport Global Advisors's GMAB Position: Q1 2022 in Review

Seaport Global Advisors sold out of Genmab (GMAB) in Q1 2022, closing a stake of 2,846 shares — an estimated $1.14M sold.

Seaport Global Advisors first reported a position in GMAB in Q4 2021 and held it in 1 quarter. The position peaked at $1.14M in Q4 2021. 204 funds tracked by Wall St. Rank hold GMAB as of Q1 2022.

  • Seaport Global Advisors reported no remaining Genmab position as of Q1 2022 after selling out during the quarter.
  • Seaport Global Advisors sold 2,846 Genmab shares in Q1 2022, an estimated $1.14M.
  • Seaport Global Advisors first reported a position in Genmab in Q4 2021 and held it in 1 quarter.
  • Seaport Global Advisors's Genmab position peaked at $1.14M in Q4 2021.
  • 204 funds tracked by Wall St. Rank held Genmab as of Q1 2022.

Based on Seaport Global Advisors's 13F filing for Q1 2022, filed 16 May 2022.